中国肿瘤临床
中國腫瘤臨床
중국종류림상
CHINESE JOURNAL OF CLINICAL ONCOLOGY
2013年
23期
1460-1463
,共4页
师鲁静%刘文志%张旭%高海德%柳仲林%崔佑刚%冯宁
師魯靜%劉文誌%張旭%高海德%柳仲林%崔祐剛%馮寧
사로정%류문지%장욱%고해덕%류중림%최우강%풍저
结肠肿瘤%完整结肠系膜切除术%动脉灌注化疗%间质缓释化疗
結腸腫瘤%完整結腸繫膜切除術%動脈灌註化療%間質緩釋化療
결장종류%완정결장계막절제술%동맥관주화료%간질완석화료
colon neoplasm%complete mesocolic excision%aterial infusion chemotherapy%interstitial sustained-release chemotherapy
目的:探讨CME联合术中动脉灌注及腹腔内间质缓释剂化疗的安全性及疗效。方法:选取行CME联合术中动脉灌注并腹腔内间质缓释剂化疗的结肠癌患者104例为试验组,98例行结肠癌根治术患者为对照组。检测患者术前、术后血常规、肝肾功能,记录术后不良反应、并发症发生率。检测试验组癌组织、癌旁组织、术后引流液以及外周血5-FU浓度。随访3年,记录两组患者局部复发率、肝脏转移率、无疾病进展生存率及总生存率。结果:两组术前、术后血常规、肝肾功能,术后不良反应、并发症发生率无显著性差异(P>0.05)。试验组癌组织中5-FU浓度明显高于癌旁组织。试验组患者术后第3天腹腔内引流液5-FU浓度显著升高,同时外周血5-FU浓度达到峰值。试验组淋巴结转移率、肝脏转移率、无疾病进展生存率及3年总生存率均明显优于对照组,差异具有统计学意义(P<0.05)。结论:试验组患者的治疗安全有效,明显提高无疾病进展生存率和3年总生存率,且能显著降低结肠癌的淋巴结转移率和肝脏转移率。
目的:探討CME聯閤術中動脈灌註及腹腔內間質緩釋劑化療的安全性及療效。方法:選取行CME聯閤術中動脈灌註併腹腔內間質緩釋劑化療的結腸癌患者104例為試驗組,98例行結腸癌根治術患者為對照組。檢測患者術前、術後血常規、肝腎功能,記錄術後不良反應、併髮癥髮生率。檢測試驗組癌組織、癌徬組織、術後引流液以及外週血5-FU濃度。隨訪3年,記錄兩組患者跼部複髮率、肝髒轉移率、無疾病進展生存率及總生存率。結果:兩組術前、術後血常規、肝腎功能,術後不良反應、併髮癥髮生率無顯著性差異(P>0.05)。試驗組癌組織中5-FU濃度明顯高于癌徬組織。試驗組患者術後第3天腹腔內引流液5-FU濃度顯著升高,同時外週血5-FU濃度達到峰值。試驗組淋巴結轉移率、肝髒轉移率、無疾病進展生存率及3年總生存率均明顯優于對照組,差異具有統計學意義(P<0.05)。結論:試驗組患者的治療安全有效,明顯提高無疾病進展生存率和3年總生存率,且能顯著降低結腸癌的淋巴結轉移率和肝髒轉移率。
목적:탐토CME연합술중동맥관주급복강내간질완석제화료적안전성급료효。방법:선취행CME연합술중동맥관주병복강내간질완석제화료적결장암환자104례위시험조,98례행결장암근치술환자위대조조。검측환자술전、술후혈상규、간신공능,기록술후불량반응、병발증발생솔。검측시험조암조직、암방조직、술후인류액이급외주혈5-FU농도。수방3년,기록량조환자국부복발솔、간장전이솔、무질병진전생존솔급총생존솔。결과:량조술전、술후혈상규、간신공능,술후불량반응、병발증발생솔무현저성차이(P>0.05)。시험조암조직중5-FU농도명현고우암방조직。시험조환자술후제3천복강내인류액5-FU농도현저승고,동시외주혈5-FU농도체도봉치。시험조림파결전이솔、간장전이솔、무질병진전생존솔급3년총생존솔균명현우우대조조,차이구유통계학의의(P<0.05)。결론:시험조환자적치료안전유효,명현제고무질병진전생존솔화3년총생존솔,차능현저강저결장암적림파결전이솔화간장전이솔。
Objective:To investigate the safety and effect of complete mesocolie excision (CME) combined with arterial infusion chemotherapy (AIC) and intra-peritoneal interstitial sustained-release chemotherapy (IPISRC). Methods:A total of 104 patients were classified under the experimental group and underwent CME combined with AIC and IPISRC. The other 98 patients were classified un-der the control group and only received radical surgery. Pre-and post-operative blood routine examinations, as well as liver and kidney function tests, were conducted for both groups. Post-operative adverse reactions and incidence of complications were recorded. Cancer and para-neoplastic tissues were sampled in experimental group. The post-surgery 5-fluorouracil (5-FU) concentration in the drainage fluid as well as those in the peripheral blood , were determined. Three-year follow-ups were conducted, during which the local recur-rence rate, liver metastasis, progression-free survival rate, and total survival rate were recorded. Results: No significant differences were found in the white blood cell count, hemoglobin count, liver and renal functions of the patients before and after the surgery, and rate of adverse reaction and complications between the two groups after surgery (P>0.05). In experimental group , the 5-FU concentra-tion was significantly higher in the cancer tissues than in the para-neoplastic tissues . The 5-FU concentration in experimental group was also significantly higher in the intra-peritoneal drainage liquid and reached its peak in the peripheral blood on day 3 post-surgery . Local recurrence and liver metastasis rates were significantly lower in experimental group than those in control group, whereas the pro-gression-free and three-year overall survival rates were significantly higher in experimental group than in control group (P<0.05). Con-clusion:The tharepy of pations of experimental goup is safe and effective. This method significantly improves the progression-free and three-year survival rates of the patients as well as significantly reduces the local recurrence and liver metastasis rates of colon cancer.